Company · CIK 0001022079 · SIC 8071 — Services-Medical Laboratories · NYSE
QUEST DIAGNOSTICS INC · DGX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 SForm 4 → | Sep 3, 5:05 pm EDT | J. E. DavisCEO and President, Director | 10,000 | $242.72 | $2,427,200 | 122,423 | −7.55% | 10b5-1 |
| Aug 28, 2026 SForm 4 → | Aug 31, 4:37 pm EDT | Michael E PrevoznikSVP & General Counsel | 22,677 | $243.11 | $5,513,083 | 37,557 | −37.6% | 10b5-1 |
| Aug 28, 2026 GMForm 4 → | Aug 31, 4:37 pm EDT | Michael E PrevoznikSVP & General Counsel | 23,677 | $112.17 | $2,543,679 | 36,557 | — | 10b5-1 |
| Jul 28, 2026 SForm 4 → | Jul 29, 5:04 pm EDT | Mark E DelaneySVP & Chief Commercial Officer | 1,600 | $235.18 | $376,288 | 10,335 | −13.4% | 10b5-1 |
| Jul 22, 2026 LForm 4 → | Jul 27, 4:35 pm EDT | Karthik KuppusamySVP, Clinical Solutions | 37 | $206.81 | $7,652 | 13,557 | — | late |
| Jul 22, 2026 LForm 4 → | Jul 27, 4:35 pm EDT | Robert B CarterDirector | 11 | $206.80 | $2,275 | 3,864 | — | late |
| Jul 22, 2026 AForm 4 → | Jul 27, 4:34 pm EDT | Vicky B GreggDirector | 72 | $206.81 | $14,890 | 18,386 | — | late |
| Jul 22, 2026 LForm 4 → | Jul 27, 4:34 pm EDT | Patrick PlewmanSVP for Diagnostic Services | 46 | $206.81 | $9,513 | 15,293 | — | late |
| Jul 22, 2026 LForm 4 → | Jul 27, 4:33 pm EDT | Timothy L MainDirector | 21 | $206.81 | $4,343 | 22,460 | — | late |
| Jul 22, 2026 AForm 4 → | Jul 27, 4:33 pm EDT | Sam SamadExecutive Vice President & CFO | 102 | $206.81 | $21,094 | 33,478 | — | late |
| Jul 22, 2026 LForm 4 → | Jul 27, 4:33 pm EDT | Wright Lassiter IIIDirector | 6 | $206.81 | $1,241 | 10,323 | — | late |
| Jul 22, 2026 LForm 4 → | Jul 27, 4:32 pm EDT | Mark E DelaneySVP & Chief Commercial Officer | 34 | $206.81 | $7,031 | 11,935 | — | late |
| Jun 4, 2026 SForm 4 → | Jun 8, 4:32 pm EDT | Karthik KuppusamySVP, Clinical Solutions | 8,147 | $200.00 | $1,629,400 | 13,510 | −37.6% | 10b5-1 |
| Jun 4, 2026 MForm 4 → | Jun 8, 4:32 pm EDT | Karthik KuppusamySVP, Clinical Solutions | 8,147 | $124.22 | $1,012,000 | 21,657 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 28, 2026 MForm 4 → | Aug 31, 4:37 pm EDT | Michael E PrevoznikSVP & General Counsel | 22,677 | $112.17 | $2,543,679 | 0 | — | 10b5-1 |
| Jul 1, 2026 AForm 4 → | Jul 2, 4:34 pm EDT | Timothy C WentworthDirector | 144 | — | — | 342 | — | |
| Jun 4, 2026 MForm 4 → | Jun 8, 4:32 pm EDT | Karthik KuppusamySVP, Clinical Solutions | 8,147 | $124.22 | $1,012,000 | 0 | — | 10b5-1 |